Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Predictive Markers Require Thorough Analytic Validation.

Troxell ML, Fulton RS, Swanson PE, Bellizzi AM, Fitzgibbons PL, Ambaye AB, Haas TS, Goldsmith JD, Loykasek PA, Miller DV, O'Malley D, Qiu J, Salama ME, Schaberg KB, Schwartz RA, Shia J, Summers TA Jr, Wu Y.

Arch Pathol Lab Med. 2019 Aug;143(8):907-909. doi: 10.5858/arpa.2019-0112-LE. No abstract available.

PMID:
31339757
2.

Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series.

Harris KM, Creswell LL, Haas TS, Thomas T, Tung M, Isaacson E, Garberich RF, Maron BJ.

Ann Intern Med. 2017 Oct 17;167(8):529-535. doi: 10.7326/M17-0847. Epub 2017 Sep 19.

PMID:
28975231
3.

Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.

Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ.

Am J Med. 2018 Feb;131(2):200.e1-200.e8. doi: 10.1016/j.amjmed.2017.09.010. Epub 2017 Sep 21.

PMID:
28943383
4.

Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.

Link MS, Bockstall K, Weinstock J, Alsheikh-Ali AA, Semsarian C, Estes NAM 3rd, Spirito P, Haas TS, Rowin EJ, Maron MS, Maron BJ.

J Cardiovasc Electrophysiol. 2017 May;28(5):531-537. doi: 10.1111/jce.13194. Epub 2017 Mar 31.

PMID:
28240435
5.

Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.

Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS.

J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063. Erratum in: J Am Coll Cardiol. 2017 Mar 28;69(12):1652.

6.

Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.

Weissler-Snir A, Hindieh W, Gruner C, Fourey D, Appelbaum E, Rowin E, Care M, Lesser JR, Haas TS, Udelson JE, Manning WJ, Olivotto I, Tomberli B, Maron BJ, Maron MS, Crean AM, Rakowski H, Chan RH.

Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005311. doi: 10.1161/CIRCIMAGING.116.005311.

PMID:
28193612
7.

Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF.

Am J Med. 2016 Nov;129(11):1170-1177. doi: 10.1016/j.amjmed.2016.02.031. Epub 2016 Apr 1.

PMID:
27039955
8.

Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy.

Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ.

Am J Cardiol. 2016 Jun 1;117(11):1808-14. doi: 10.1016/j.amjcard.2016.03.018. Epub 2016 Mar 19.

PMID:
27089980
9.

Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes?

Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S.

Am J Cardiol. 2016 Apr 15;117(8):1339-41. doi: 10.1016/j.amjcard.2016.01.026. Epub 2016 Feb 1.

PMID:
26949036
10.

Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.

Chan RH, Maron BJ, Olivotto I, Assenza GE, Haas TS, Lesser JR, Gruner C, Crean AM, Rakowski H, Rowin E, Udelson J, Lombardi M, Tomberli B, Spirito P, Formisano F, Marra MP, Biagini E, Autore C, Manning WJ, Appelbaum E, Roberts WC, Basso C, Maron MS.

Am J Cardiol. 2015 Aug 1;116(3):436-41. doi: 10.1016/j.amjcard.2015.04.060. Epub 2015 May 8.

PMID:
26026863
11.

Under-recognition of aortic and aortic valve disease and the risk for sudden death in competitive athletes.

Harris KM, Tung M, Haas TS, Maron BJ.

J Am Coll Cardiol. 2015 Mar 3;65(8):860-862. doi: 10.1016/j.jacc.2014.09.094. No abstract available.

12.

Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.

Hoang LL, Tacha D, Bremer RE, Haas TS, Cheng L.

Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):711-6. doi: 10.1097/PAI.0000000000000143.

PMID:
25611245
13.

Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.

Biagini E, Olivotto I, Iascone M, Parodi MI, Girolami F, Frisso G, Autore C, Limongelli G, Cecconi M, Maron BJ, Maron MS, Rosmini S, Formisano F, Musumeci B, Cecchi F, Iacovoni A, Haas TS, Bacchi Reggiani ML, Ferrazzi P, Salvatore F, Spirito P, Rapezzi C.

Am J Cardiol. 2014 Sep 1;114(5):769-76. doi: 10.1016/j.amjcard.2014.05.065. Epub 2014 Jun 19.

PMID:
25037680
14.

A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder.

Hoang LL, Tacha DE, Qi W, Yu C, Bremer RE, Chu J, Haas TS, Cheng L.

Arch Pathol Lab Med. 2014 Jul;138(7):943-9. doi: 10.5858/arpa.2013-0221-OA.

PMID:
24978921
15.

Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.

Gruner C, Chan RH, Crean A, Rakowski H, Rowin EJ, Care M, Deva D, Williams L, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Siminovitch K, Ralph-Edwards AC, Rastegar H, Maron BJ, Maron MS.

Eur Heart J. 2014 Oct 14;35(39):2706-13. doi: 10.1093/eurheartj/ehu154. Epub 2014 May 8.

16.

Hypertrophic cardiomyopathy: one gene … but many phenotypes.

Maron BJ, Haas TS, Goodman JS.

Am J Cardiol. 2014 May 15;113(10):1772-3. doi: 10.1016/j.amjcard.2014.02.032. Epub 2014 Mar 6. No abstract available.

PMID:
24792744
17.

Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes.

Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF.

Int J Cardiol. 2014 May 15;173(3):369-72. doi: 10.1016/j.ijcard.2014.02.021. Epub 2014 Feb 22.

PMID:
24704402
18.

Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center.

Fitzgibbons PL, Bradley LA, Fatheree LA, Alsabeh R, Fulton RS, Goldsmith JD, Haas TS, Karabakhtsian RG, Loykasek PA, Marolt MJ, Shen SS, Smith AT, Swanson PE; College of American Pathologists Pathology and Laboratory Quality Center.

Arch Pathol Lab Med. 2014 Nov;138(11):1432-43. doi: 10.5858/arpa.2013-0610-CP. Epub 2014 Mar 19.

PMID:
24646069
19.

Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors.

Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS, Bongioanni S, Semsarian C, Devoto E, Musumeci B, Lai F, Yeates L, Conte MR, Rapezzi C, Boni L, Maron BJ.

Am J Cardiol. 2014 May 1;113(9):1550-5. doi: 10.1016/j.amjcard.2014.01.435. Epub 2014 Feb 12.

PMID:
24630786
20.

Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.

Maron BJ, Haas TS, Maron MS, Lesser JR, Browning JA, Chan RH, Olivotto I, Garberich RF, Schwartz RS.

Am J Cardiol. 2014 Apr 15;113(8):1394-400. doi: 10.1016/j.amjcard.2013.12.045. Epub 2014 Jan 31.

PMID:
24589281
21.

Incidence and causes of sudden death in U.S. college athletes.

Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S.

J Am Coll Cardiol. 2014 Apr 29;63(16):1636-43. doi: 10.1016/j.jacc.2014.01.041. Epub 2014 Feb 26.

22.

A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomas.

Hoang LL, Tang P, Hicks DG, Chen H, Yang Q, Haas TS, Bremer RE, Tacha D.

Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):606-12. doi: 10.1097/PAI.0b013e3182a4edef.

PMID:
24569788
23.

Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.

Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, Gibson CM, Nistri S, Servettini E, Chan RH, Udelson JE, Lesser JR, Cecchi F, Manning WJ, Maron MS.

J Am Coll Cardiol. 2013 Jul 30;62(5):449-57. doi: 10.1016/j.jacc.2013.03.062. Epub 2013 Apr 30.

24.

Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.

Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, Garberich RF, Lesser JR, Appelbaum E, Manning WJ, Maron MS.

Circulation. 2013 Feb 5;127(5):585-93. doi: 10.1161/CIRCULATIONAHA.112.136085. Epub 2012 Dec 30.

PMID:
23275385
25.

Reply: To PMID 22809753.

Maron BJ, Harris KM, Haas TS, Eichner ER.

Am J Cardiol. 2013 Jan 1;111(1):149. doi: 10.1016/j.amjcard.2012.09.008. No abstract available.

PMID:
23245840
26.

Incidence of cardiovascular sudden deaths in Minnesota high school athletes.

Maron BJ, Haas TS, Ahluwalia A, Rutten-Ramos SC.

Heart Rhythm. 2013 Mar;10(3):374-7. doi: 10.1016/j.hrthm.2012.11.024. Epub 2012 Dec 1.

PMID:
23207138
27.

Increasing survival rate from commotio cordis.

Maron BJ, Haas TS, Ahluwalia A, Garberich RF, Estes NA 3rd, Link MS.

Heart Rhythm. 2013 Feb;10(2):219-23. doi: 10.1016/j.hrthm.2012.10.034. Epub 2012 Oct 26.

PMID:
23107651
28.

Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.

Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA 3rd, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ.

Heart Rhythm. 2013 Feb;10(2):214-8. doi: 10.1016/j.hrthm.2012.10.003. Epub 2012 Oct 4.

PMID:
23041573
29.

Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.

Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS.

Am J Cardiol. 2012 Oct 1;110(7):1027-32. doi: 10.1016/j.amjcard.2012.05.035. Epub 2012 Jul 16.

PMID:
22809754
30.

Sickle cell trait associated with sudden death in competitive athletes.

Harris KM, Haas TS, Eichner ER, Maron BJ.

Am J Cardiol. 2012 Oct 15;110(8):1185-8. doi: 10.1016/j.amjcard.2012.06.004. Epub 2012 Jul 16.

PMID:
22809753
31.

Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.

Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ.

Circ Cardiovasc Imaging. 2012 Jul;5(4):441-7. doi: 10.1161/CIRCIMAGING.112.972760. Epub 2012 May 4.

PMID:
22563033
32.

Hypertrophic cardiomyopathy with longevity to 90 years or older.

Maron BJ, Casey SA, Haas TS, Kitner CL, Garberich RF, Lesser JR.

Am J Cardiol. 2012 May 1;109(9):1341-7. doi: 10.1016/j.amjcard.2011.12.027. Epub 2012 Feb 28.

PMID:
22381158
33.

Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.

Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS.

Circ Cardiovasc Imaging. 2012 Jan;5(1):78-85. doi: 10.1161/CIRCIMAGING.111.963819. Epub 2011 Dec 1.

PMID:
22135401
34.

Onset of apical hypertrophic cardiomyopathy in adulthood.

Maron BJ, Haas TS, Kitner C, Lesser JR.

Am J Cardiol. 2011 Dec 15;108(12):1783-7. doi: 10.1016/j.amjcard.2011.07.048. Epub 2011 Sep 28.

PMID:
21958740
35.

Global epidemiology and demographics of commotio cordis.

Maron BJ, Ahluwalia A, Haas TS, Semsarian C, Link MS, Estes NA 3rd.

Heart Rhythm. 2011 Dec;8(12):1969-71. doi: 10.1016/j.hrthm.2011.07.014. Epub 2011 Jul 18.

PMID:
21763255
36.

Epidemiology of sudden death in young, competitive athletes due to blunt trauma.

Thomas M, Haas TS, Doerer JJ, Hodges JS, Aicher BO, Garberich RF, Mueller FO, Cantu RC, Maron BJ.

Pediatrics. 2011 Jul;128(1):e1-8. doi: 10.1542/peds.2010-2743. Epub 2011 Jun 20.

PMID:
21690117
37.

Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.

Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron BJ.

Circulation. 2011 Jul 5;124(1):40-7. doi: 10.1161/CIRCULATIONAHA.110.985812. Epub 2011 Jun 13.

PMID:
21670234
38.

Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy.

Maron BJ, Maron MS, Maron BA, Haas TS, Altman RK, Smalley SJ, Doerer JJ, Link MS, Mooney MR.

J Am Coll Cardiol. 2011 Jun 14;57(24):2454-6. doi: 10.1016/j.jacc.2011.03.021. No abstract available.

39.

The College of American Pathologists and National Society for Histotechnology workload study.

Kohl SK, Lewis SE, Tunnicliffe J, Lott RL, Spencer LT, Carson FL, Souers RJ, Knapp RH, Movahedi-Lankarani S, Haas TS, Brown RW.

Arch Pathol Lab Med. 2011 Jun;135(6):728-36. doi: 10.1043/2010-0288-CP.1.

PMID:
21631265
40.

"Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years.

Maron BJ, Lindberg J, Haas TS, Kitner C, Schum K, Lesser JR, Maron MS.

Am J Cardiol. 2011 Jun 15;107(12):1862-3. doi: 10.1016/j.amjcard.2011.01.062. Epub 2011 Apr 12.

PMID:
21482415
41.

Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.

Bos JM, Maron BJ, Ackerman MJ, Haas TS, Sorajja P, Nishimura RA, Gersh BJ, Ommen SR.

Am J Cardiol. 2010 Nov 15;106(10):1481-6. doi: 10.1016/j.amjcard.2010.06.077.

PMID:
21059440
42.

Profound left ventricular remodeling associated with LAMP2 cardiomyopathy.

Maron BJ, Roberts WC, Ho CY, Kitner C, Haas TS, Wright GB, Moazami N, Feldman DS.

Am J Cardiol. 2010 Oct 15;106(8):1194-6. doi: 10.1016/j.amjcard.2010.06.035.

PMID:
20920663
43.

Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall.

Maron BJ, Sherrid MV, Haas TS, Lindberg J, Kitner C, Lesser JR.

Am J Cardiol. 2010 Sep 1;106(5):750-2. doi: 10.1016/j.amjcard.2010.04.037.

PMID:
20723657
44.

Disparity between unusual left ventricular morphology and clinical presentation and course in hypertrophic cardiomyopathy.

Maron BJ, Lindberg J, Haas TS, Kitner C, Lesser JR.

Am J Cardiol. 2010 Jun 1;105(11):1643-4. doi: 10.1016/j.amjcard.2010.01.334. No abstract available.

PMID:
20494677
45.

Sudden death during the triathlon.

Harris KM, Henry JT, Rohman E, Haas TS, Maron BJ.

JAMA. 2010 Apr 7;303(13):1255-7. doi: 10.1001/jama.2010.368. No abstract available.

PMID:
20371783
46.

Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, Haas TS, Hodges JS, Maron BJ.

J Am Coll Cardiol. 2010 Jan 26;55(4):333-41. doi: 10.1016/j.jacc.2009.08.057.

47.

Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.

Sherrid MV, Cotiga D, Hart D, Ehlert F, Haas TS, Shen WK, Link MS, Estes NA 3rd, Epstein AE, Semsarian C, Daubert JP, Winters SL, Giudici MC, Maron BJ.

Am J Cardiol. 2009 Dec 15;104(12):1722-6. doi: 10.1016/j.amjcard.2009.07.056.

PMID:
19962483
48.

Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography.

Knickelbine T, Lesser JR, Haas TS, Brandenburg ER, Gleason-Han BK, Flygenring B, Longe TF, Schwartz RS, Maron BJ.

JACC Cardiovasc Imaging. 2009 Sep;2(9):1085-92. doi: 10.1016/j.jcmg.2009.03.022.

49.

Commotio cordis and the epidemiology of sudden death in competitive lacrosse.

Maron BJ, Doerer JJ, Haas TS, Estes NA, Hodges JS, Link MS.

Pediatrics. 2009 Sep;124(3):966-71. doi: 10.1542/peds.2009-0167. Epub 2009 Aug 10.

PMID:
19706581
50.

Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies.

Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS.

Am J Cardiol. 2009 Jul 15;104(2):276-80. doi: 10.1016/j.amjcard.2009.03.037. Epub 2009 May 18.

PMID:
19576360

Supplemental Content

Support Center